TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06308783

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diaphragmatic Breathing
Description: 10 minutes each day during 6 weeks, before sleeping.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Global Postural Reeducation
Description: 10 minutes each day during 6 weeks, before sleeping.
Study: NCT06277375

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Massage
Description: The application starts from the neck with small circular strokes with the thumbs. Surface strokes are performed with the palm of the hand from the base of the skull towards the sacral region. Then rhythmic strokes are repeated from the sacrum along the entire spine towards the skull.The application to the experimental group will be done 3 days a week for 10 minutes for a total of 30 minutes.
Study: NCT05991817

Intervention type: PROCEDURE
Intervention: Surgery/general anesthesia
Description: Adult patients between the ages of 30 and 50 who are to undergo elective surgery under general anesthesia will have their spatial memory tested and interleukin 1beta and alpha tumor necrosis measured before and after surgery.
Study: NCT05871476

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Hospital Cohort Care Intervention at the hospital
Description: There will be 3 different cohort groups for the patients: 1) Unknown CRE colonisation status with increased barrier precautions (all patients until screening results arrive will belong to this group unless there are available screening results from referral hospital), 2) CREpos, and 3) CREneg. CREpos patients (2) will be treated in one area of the ICUs by specially assigned nurses/personnel.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: , Household Education Communication Hygiene Intervention, Livestock Antibiotic Intervention
Description: The intervention will focus on two main measurable outcomes: 1) Decrease feco-oral-animal transmission route to prevent in-HH and community spread of CRE +/- CoRE. 2) Decrease unindicated community use of ABs for humans and animals. This WP focuses on a one health intervention in collaboration with local health authorities, developing and implementing an HH Education Communication Hygiene Intervention (HECHI) to improve HH hygiene and health management and reduce the risk of transmission between humans and animals, a Provider Engagement Intervention (PEI) to improve case management of common infection and decrease unindicated AB, and and a Livestock AB Intervention (LAI) to reduce the use of AB in livestock through improved biosecurity conditions and animal husbandry.
Study: NCT05370118

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telerehabilitation physical activity behavioral (TPAB) intervention
Description: The intervention includes the behavior change techniques of self-monitoring of behavior, action planning, graded tasks, restructuring the physical and social environment, problem-solving, and prompts/cues.
Study: NCT06514131

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pre-moistened wipes
Description: Patients receiving the experimental treatment will have perineal hygiene performed with the pre-moistened wipes without water
Study: NCT04683575

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selenium Yeast
Description: oral medication

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: oral medication
Study: NCT06425640

Intervention type: BEHAVIORAL
Intervention: 24-hour movement behavior
Description: Cross-sectional observational study investigating the 24-hour movement behaviors and glucose control
Study: NCT06055387

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Frailty intervention measures
Description: Providing specialized guidance:~* Physical Function and Fall History:~  * Prioritizing home safety for those with physical impairments.~ * Arranging rehab consultations when necessary.~* Nutrition:~  * Assessing diets and offering education.~ * Pre-treatment nutritionist assessments.~ * Monitoring weight, intervening if \>5-10% loss, or \>10% loss.~* Social Support:~  * Evaluating the needs of those without family support.~ * Referring to social services and introducing care resources.~* Cognition:~  * Detecting cognitive issues, addressing reversible causes.~ * Assessing decision-making and medication self-administration.~ * Refer to specialists when needed.~* Polypharmacy and Comorbidity:~  * Collecting medication data, ensuring adherence.~ * Noting chronic illnesses.~ * Collaborating with specialists or pharmacists for complex cases.~* Psychological:~  * Providing weekly support for psychological concerns.~ * Refer to specialists for assessments and treatment options.
Study: NCT05391672

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Repair or Aumentation of partial ACL tear
Description: We will use repair technique in one grouo and Augmentation in the other group

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Repair or Aumentation of partial ACL tear
Description: We will use repair technique in one grouo and Augmentation in the other group
Study: NCT05096377

Intervention type: OTHER
Intervention: ESP block
Description: ESP block performed using ultrasound guidance. Diaphragmatic excursion was measured using M-mode ultrasound during normal breathing, deep breathing and with the sniff manoeuvre.
Study: NCT05225740

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Exposure
Description: The standard intervention will include an orientation and psychoeducation phase, an exposure practice phase consisting five repeated trials per each of the three exposure exercises, and a post-exposure exercise. The post-exposure exercise will involve completing a set of questions regarding the exercises and the group experience.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Stress Management Training
Description: Stress management training (SMT) is designed to help people better cope with feelings of anxiety that accompany high levels of anxiety sensitivity. SMT will involve group instruction in healthy ways to experience and cope with stress whenever difficult situations arise. Participants will teach participants ways to maintain a healthy lifestyle, targeting things like nutrition, exercise, and sleep hygiene. This intervention will also involve progressive muscle relaxation training.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Exposure
Description: The enhanced intervention will include an orientation and psychoeducation phase, an exposure practice phase consisting five repeated trials per each of the three exposure exercises, and a processing exercise. The post-processing exercise will involve completing a set of questions that will highlight harm expectancy violations.
Study: NCT06426745

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bowel preparation
Description: to compare bowel cleanliness, compliance, tolerability, and patient satisfaction of a single regimen versus a split regimen for colonoscopy.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bowel preparation
Description: to compare bowel cleanliness, compliance, tolerability, and patient satisfaction of a single regimen versus a split regimen for colonoscopy.
Study: NCT05759871

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: GnRH antagonist
Description: The GnRH antagonist in the control group (standard therapy) is administered from day 6 of FSH treatment at the dose of 0.25 mg per day until the triggering day and is injected each time immediately after the injection of FSH.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: GnRH antagonist
Description: The GnRH antagonist in the control group (standard therapy) is administered from day 6 of FSH treatment at the dose of 0.25 mg per day until the triggering day and is injected each time immediately after the injection of FSH.
Study: NCT04156659

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tisagenlecleucel
Description: A single intravenous (i.v.) infusion of CAR-positive viable T cells.
Study: NCT05793658

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard capnography
Description: Patients undergoing colonoscopy under sedation were randomly assigned to receive standard capnography monitoring or modified capnography monitoring which can be achieved by tucking capnography probe under the face mask.74 patients were enrolled. Patient characteristics were well balanced between the two groups 37 patients in each group.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Modified capnography
Description: If Respiratory rate below 14 b/m: more sedation isn't not advised and the patient may develop airway obstruction and needs airway intervention ( like jaw thrust or oral airway) If respiratory rate more than 20 b/m it means this patient is prone to awake or to move and this patient in need for incremental dose of sedative drug ( e.g 20 to 30 mg propofol) Also roughly speaking respiratory rate from 16 to 18 b/m is the target
Study: NCT03966989

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Performance Feedback
Description: Performance feedback offline that benchmarks providers' own performance to that of their peers
Study: NCT05856968

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: continuous subcutaneous tissue closure
Description: The use of continuous subcutaneous tissue closure to determine which closure results in a lower rate of surgical site infection.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Interrupted subcutaneous tissue closure
Description: The use of interrupted subcutaneous tissue closure to determine which closure results in a lower rate of surgical site infection.
Study: NCT04753801

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Thinking, writing and imagination
Description: All participants are asked to take some time to think and write about the respective intervention group's content. In some groups (after the writing exercise (approx. 15min)), participants are also asked to imagine that content or engage in a mindfulness activity or recall task for about 5 minutes.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Thinking, writing and imagination
Description: All participants are asked to take some time to think and write about the respective intervention group's content. In some groups (after the writing exercise (approx. 15min)), participants are also asked to imagine that content or engage in a mindfulness activity or recall task for about 5 minutes.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Thinking, writing and imagination
Description: All participants are asked to take some time to think and write about the respective intervention group's content. In some groups (after the writing exercise (approx. 15min)), participants are also asked to imagine that content or engage in a mindfulness activity or recall task for about 5 minutes.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Thinking, writing and imagination
Description: All participants are asked to take some time to think and write about the respective intervention group's content. In some groups (after the writing exercise (approx. 15min)), participants are also asked to imagine that content or engage in a mindfulness activity or recall task for about 5 minutes.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Thinking, writing and imagination
Description: All participants are asked to take some time to think and write about the respective intervention group's content. In some groups (after the writing exercise (approx. 15min)), participants are also asked to imagine that content or engage in a mindfulness activity or recall task for about 5 minutes.
Study: NCT05530005

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Manual Therapy
Description: Manual Therapy according to Kaltenborn Evjenth method. Exercises with PT resistance, massage.
Study: NCT04780399

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Yangxue Qingnao pills
Description: 72 subjects in the Yangxue Qingnao pills group take 7.5g of Yangxue Qingnao pills each time, twice a day, 0.5 hours after breakfast and dinner, taking with warm water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Yangxue Qingnao pills
Description: 72 subjects in the Yangxue Qingnao pills group take 5g of Yangxue Qingnao pills and 2.5g placebo identified to Yangxue Qingnao pills each time, twice a day, 0.5 hours after breakfast and dinner, taking with warm water.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 72 subjects in the placebo group take 7.5g placebo identified to Yangxue Qingnao pills each time, twice a day, 0.5 hours after breakfast and dinner, taking with warm water.
Study: NCT06078982

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Disitamab Vedotin
Description: 2.0mg/kg, intravenously D1, once every 14 days (Q2W)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toripalimab
Description: 3.0 mg/kg, once every 14 days (Q2W)
Study: NCT04676373

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALGLUCOSIDASE ALFA
Description: Pharmaceutical form:solution for infusion~Route of administration: intravenous
Study: NCT06514235

Intervention type: OTHER
Intervention: Observational study (Non-interventional study)
Description: This is an observational study.
Study: NCT05424120

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Manual aspiration
Description: One option from standard of care

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Wall suction
Description: One option from standard of care

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Vacuum bottle drainage
Description: One option from standard of care
Study: NCT05396690

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remimazolam Injection [Byfavo]
Description: Induction dose: 6 mg/kg/h with sufentanil Maintenance dose: 1\~2 mg/kg/h with sufentanil If arousal occurs during surgery, rapidly increase the infusion rate of remimazolam to 12 mg/kg/h and infuse for 1 minute. If the patient's arousal persists after these measures, stop remimazolam infusion and replace with another drug.

Intervention type: DRUG
Group type: OTHER
Intervention: Sevoflurane
Description: Induction dose: 2\~3 mg midazolam with sufentanil Maintenance: Adjust the concentration to be BIS 35-65 based on 0.5 mac If arousal occurs during surgery, raise the concentration of sevoflurane to 1.5 MAC (increase the total gas flow rate to 8 l/min) and if arousal persists after 1 minute, administer midazolam 2-3 mg.
Study: NCT05634291

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard of care
Description: Standard of care as prescribed by healthcare provider.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nottingham AR smartphone app with active intervention
Description: AR software treatment delivered by smartphone app and developed by VRx Medical (VRx) using established principles of illusion therapies (e.g. mirror therapy) for pain management.
Study: NCT05020353

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: OraQuick® HIV Self-Test
Description: OraQuick® HIV Self-Test in oral fluid conducted by observed intended users (non-healthcare professional and inexperienced in HIV self-testing) compared to laboratory 4th generation Ag/Ab enzyme immunoassay (EIA) results performed on venous blood.
Study: NCT06042075

Intervention type: OTHER
Intervention: Questionnaire on congenital birthmarks
Description: Questions will be put to health professionals on representation using a semi-quantitative questionnaire.
Study: NCT06157437

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Focal Pulse field Ablation
Description: Bidirectional block of the cavo-tricuspid isthmus (CTI) was performed with the novel focal pulse field ablation.
Study: NCT03243149

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: fMRI - GE Medical System
Description: Recovery from PTSD symptoms has been modeled experimentally as fear extinction that depends on three interconnected brain regions that involve the amygdala where extinction memories are stored, the subcallosal/subgenual cortex within the medial PFC involved in consolidation of the extinction memory, and the hippocampus which mediates the context specificity of context specificity of extinction.~The two MRI systems are used for human research by many faculty and research groups at Duke and UNC, Chapel Hill. The center has two research dedicated General Electric MR 750 scanners with a field strength of 3 Tesla. These systems use a combination of General Electric production pulse sequences and custom research pulse sequences that have been developed by Brain Imaging and Analysis Center faculty and other MR physicists. The scanners are used for imaging and spectroscopy.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: fMRI - GE Medical System
Description: Recovery from PTSD symptoms has been modeled experimentally as fear extinction that depends on three interconnected brain regions that involve the amygdala where extinction memories are stored, the subcallosal/subgenual cortex within the medial PFC involved in consolidation of the extinction memory, and the hippocampus which mediates the context specificity of context specificity of extinction.~The two MRI systems are used for human research by many faculty and research groups at Duke and UNC, Chapel Hill. The center has two research dedicated General Electric MR 750 scanners with a field strength of 3 Tesla. These systems use a combination of General Electric production pulse sequences and custom research pulse sequences that have been developed by Brain Imaging and Analysis Center faculty and other MR physicists. The scanners are used for imaging and spectroscopy.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: fMRI - GE Medical System
Description: Recovery from PTSD symptoms has been modeled experimentally as fear extinction that depends on three interconnected brain regions that involve the amygdala where extinction memories are stored, the subcallosal/subgenual cortex within the medial PFC involved in consolidation of the extinction memory, and the hippocampus which mediates the context specificity of context specificity of extinction.~The two MRI systems are used for human research by many faculty and research groups at Duke and UNC, Chapel Hill. The center has two research dedicated General Electric MR 750 scanners with a field strength of 3 Tesla. These systems use a combination of General Electric production pulse sequences and custom research pulse sequences that have been developed by Brain Imaging and Analysis Center faculty and other MR physicists. The scanners are used for imaging and spectroscopy.
Study: NCT04742218

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: K-877
Description: K-877 Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: K-877
Description: K-877 Tablet
Study: NCT05282784

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hyperthermia
Description: Patients will be treated with hyperthermia 2 or 3 times a week. Treatment will be performed for 1 hours per each visit.~Patients will be treated with radiotherapy 5 times a week.

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiotherapy
Description: Patients will be treated with radiotherapy 5 times a week.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Description: Patients will be treated with radiotherapy 5 times a week.
Study: NCT04459338

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Exendin-9,39
Description: Exendin-9,39 is a competitive antagonist of GLP-1 actions at the GLP-1 receptor

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Exendin-9,39
Description: Exendin-9,39 is a competitive antagonist of GLP-1 actions at the GLP-1 receptor

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Saline
Description: Placebo comparator

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Saline
Description: Placebo comparator
Study: NCT05269329

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XC8, film-coated tablets, 20 mg/day
Description: 20 mg/day (1 tablet twice a day)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XC8, film-coated tablets, 40 mg/day
Description: 40 mg/day (2 tablets twice a day)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XC8, film-coated tablets, 80 mg/day
Description: 80 mg/day (4 tablets twice a day)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1, 2, or 4 tablets twice a day
Study: NCT05762575

Intervention type: OTHER
Intervention: knotting methods
Description: The volunteers in experimental group study new knotting technology.

Intervention type: OTHER
Intervention: knotting methods
Description: The volunteers in experimental group study new knotting technology.
Study: NCT05555680

Intervention type: OTHER
Intervention: Ferriman-Gallwey Score
Description: The Ferriman-Gallwey score is used to evaluate hirsutism. The examiner scores the subjects on a scale of 0-4 for terminal hair growth on eleven different body areas according to the Ferriman-Gallwey scoring system. A Ferriman-Gallwey score of 8 or more was considered diagnostic of hirsutism

Intervention type: OTHER
Intervention: Ferriman-Gallwey Score
Description: The Ferriman-Gallwey score is used to evaluate hirsutism. The examiner scores the subjects on a scale of 0-4 for terminal hair growth on eleven different body areas according to the Ferriman-Gallwey scoring system. A Ferriman-Gallwey score of 8 or more was considered diagnostic of hirsutism